Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Nov;65(11):1521-4.
doi: 10.1136/ard.2005.045484.

Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial

N Putschky  1 , H-G Pott, J G Kuipers, H Zeidler, M Hammer, J Wollenhaupt
Affiliations
Randomized Controlled Trial

Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial

N Putschky et al. Ann Rheum Dis. 2006 Nov.

Abstract

Objective: To compare the efficacy of a 10-day and a 4-month doxycylcine course for the treatment of Chlamydia trachomatis-reactive arthritis (Ct-ReA).

Methods: Patients with active Ct-ReA were enrolled in a prospective, multicentre, double-blind, controlled clinical trial and randomised to receive doxycycline 100 mg twice daily for 10 days followed either by placebo or by continued doxycycline 100 mg twice daily over 4 months. Various clinical and laboratory parameters referring to disease activity were recorded in the beginning and at the end of treatment.

Results: 32 of 37 patients included (15 men and 17 women; mean (standard deviation) disease duration 17 (13) months completed the study; 17 were randomised to short-term doxycycline and placebo (placebo group) and 15 to prolonged treatment with doxycycline (doxycycline group) over the 4-month study period. After this time, only two patients from each group went into remission. There were no drop-outs owing to adverse events or treatment failures.

Conclusions: The results of this study suggest that prolonged treatment with a 4-month course of doxycycline is not superior to short-term treatment over 10 days in patients with Ct-ReA.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Wollenhaupt J, Zeidler H. Undifferentiated arthritis and reactive arthritis. Curr Opin Rheumatol 199810306–313. - PubMed
    1. Fox R, Colin A, Gerber R C, Gibson D. The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med 197991190–193. - PubMed
    1. Hughes R A, Keat A C. Reiter's syndrome and reactive arthritis: a current review.Semin Arthritis Rheum 199424190–210. - PubMed
    1. Wollenhaupt J, Kolbus F, Weißbrodt H, Schneider C, Krech T, Zeidler H. Manifestations of Chlamydia induced arthritis in patients with silent versus symptomatic urogenital chlamydial infection. Clin Exp Rheumatol 199513453–458. - PubMed
    1. Braun J, Eggens U, Sieper J. Can antimicrobial drugs really cure reactive arthritis? Evidence from studies of ciprofloxacin and other drugs. Ann Rheum Dis 199655578

Publication types